Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 24


Discriminatory capacity between HIV-1 and HIV-2 of the new rapid confirmation assay Geenius.

Herssens N, Beelaert G, Fransen K.

J Virol Methods. 2014 Nov;208:11-5. doi: 10.1016/j.jviromet.2014.07.025. Epub 2014 Jul 27.


Use of rapid HIV testing in a low threshold centre in Antwerp, Belgium, 2007-2012.

Wouters K, Fransen K, Beelaert G, Kenyon C, Platteau T, Van Ghyseghem C, Collier I, Buyze J, Florence E.

Int J STD AIDS. 2014 Nov;25(13):936-42. doi: 10.1177/0956462414526705. Epub 2014 Apr 3.


Using conventional HIV tests on oral fluid.

Fransen K, Vermoesen T, Beelaert G, Menten J, Hutse V, Wouters K, Platteau T, Florence E.

J Virol Methods. 2013 Dec;194(1-2):46-51. doi: 10.1016/j.jviromet.2013.08.004. Epub 2013 Aug 19.


Assessment of desiccants and their instructions for use in rapid diagnostic tests.

Barbé B, Gillet P, Beelaert G, Fransen K, Jacobs J.

Malar J. 2012 Sep 13;11:326. doi: 10.1186/1475-2875-11-326.


Preexposure prophylaxis for HIV infection among African women.

Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, Malahleha M, Owino F, Manongi R, Onyango J, Temu L, Monedi MC, Mak'Oketch P, Makanda M, Reblin I, Makatu SE, Saylor L, Kiernan H, Kirkendale S, Wong C, Grant R, Kashuba A, Nanda K, Mandala J, Fransen K, Deese J, Crucitti T, Mastro TD, Taylor D; FEM-PrEP Study Group.

N Engl J Med. 2012 Aug 2;367(5):411-22. doi: 10.1056/NEJMoa1202614. Epub 2012 Jul 11.


A venue-based HIV prevalence and behavioural study among men who have sex with men in Antwerp and Ghent, Flanders, Belgium, October 2009 to March 2010.

Vanden Berghe W, Nostlinger C, Buvé A, Beelaert G, Fransen K, Laga M.

Euro Surveill. 2011 Jul 14;16(28). pii: 19914.


Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial.

Crucitti T, Taylor D, Beelaert G, Fransen K, Van Damme L.

Clin Vaccine Immunol. 2011 Sep;18(9):1480-5. doi: 10.1128/CVI.05069-11. Epub 2011 Jul 13.


Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial.

Crucitti T, Fransen K, Maharaj R, Tenywa T, Massinga Loembé M, Murugavel KG, Mendonca K, Abdellati S, Beelaert G, Van Damme L.

PLoS One. 2010 Oct 27;5(10):e13592. doi: 10.1371/journal.pone.0013592.


Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa.

Chaillet P, Tayler-Smith K, Zachariah R, Duclos N, Moctar D, Beelaert G, Fransen K.

Trans R Soc Trop Med Hyg. 2010 Sep;104(9):571-6. doi: 10.1016/j.trstmh.2010.05.007. Epub 2010 Jun 17.


Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness.

Lejon V, Ngoyi DM, Ilunga M, Beelaert G, Maes I, Büscher P, Fransen K.

J Clin Microbiol. 2010 Aug;48(8):2836-9. doi: 10.1128/JCM.00456-10. Epub 2010 Jun 23.


Evaluation of a rapid and simple fourth-generation HIV screening assay for qualitative detection of HIV p24 antigen and/or antibodies to HIV-1 and HIV-2.

Beelaert G, Fransen K.

J Virol Methods. 2010 Sep;168(1-2):218-22. doi: 10.1016/j.jviromet.2010.06.002. Epub 2010 Jun 16.


Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.

Van Damme L, Govinden R, Mirembe FM, Guédou F, Solomon S, Becker ML, Pradeep BS, Krishnan AK, Alary M, Pande B, Ramjee G, Deese J, Crucitti T, Taylor D; CS Study Group.

N Engl J Med. 2008 Jul 31;359(5):463-72. doi: 10.1056/NEJMoa0707957. Erratum in: N Engl J Med. 2008 Aug 21;359(8):877.


Pediatric human immunodeficiency virus screening in an African district hospital.

De Baets AJ, Edidi BS, Kasali MJ, Beelaert G, Schrooten W, Litzroth A, Kolsteren P, Denolf D, Fransen K.

Clin Diagn Lab Immunol. 2005 Jan;12(1):86-92.


Comparative evaluation of eight commercial enzyme linked immunosorbent assays and 14 simple assays for detection of antibodies to HIV.

Beelaert G, Vercauteren G, Fransen K, Mangelschots M, De Rooy M, Garcia-Ribas S, van der Groen G.

J Virol Methods. 2002 Sep;105(2):197-206.


Evaluation of four HIV antigen tests.

Fransen K, Beelaert G, van der Groen G.

J Virol Methods. 2001 Apr;93(1-2):189-93.


HIV testing in developing countries.

Colebunders R, Beelaert G, Wellens R.

Lancet. 1997 Apr 26;349(9060):1258. No abstract available.


Evaluation of an agglutination HIV-1 + 2 antibody assay.

Vercauteren G, Beelaert G, van der Groen G.

J Virol Methods. 1995 Jan;51(1):1-8.


Eradication of hantavirus infection among laboratory rats by application of caesarian section and a foster mother technique.

McKenna P, van der Groen G, Hoofd G, Beelaert G, Leirs H, Verhagen R, Kints JP, Cormont F, Nisol F, Bazin H.

J Infect. 1992 Sep;25(2):181-90.


Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.

Fransen K, Pollet DE, Peeters M, van Kerckhoven I, Beelaert G, Vercauteren G, Piot P, van der Groen G.

Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):939-46.


Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides.

Pollet DE, Saman EL, Peeters DC, Warmenbol HM, Heyndrickx LM, Wouters CJ, Beelaert G, van der Groen G, Van Heuverswyn H.

Clin Chem. 1991 Oct;37(10 Pt 1):1700-7.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk